Floor Tile Removal Will Bar Access to Some MSB Rooms
Workers will be removing floor tile on the east side of the Medical Sciences Building (MSB) in the 300 series hallways on Levels 4, 5, 6 and 7 this weekend to prepare for installation of temporary construction barricades for Phase IV of the MSB Rehabilitation project.
Work is being performed on a weekend to limit disruption of normal activities. It will start at 8 p.m. Friday, June 14, and will be complete by 5 p.m. Sunday, June 16. Work will be performed inside plastic containment with an exhaust system to keep dust to a minimum. There will be localized noise but no hammer drilling.
During the weekend, there will not be any access to the following rooms:
Level 4: 4352, 4356, 4357, 4358 (offices A to D).
Level 5: 5353, 5355, 5356, 5357.
Level 6: 6356, 6359, 6360.
Level 7: 7350, 7354, 7357, 7358.
Phase IV of the MSB Rehabilitation Project involves the south half of the MSB (Levels E-7 in the southeast quadrant and Levels 3-7 in the southwest quadrant).
Tags
Related Stories
Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December
December 12, 2025
This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.
Ohio nurses weigh in on proposed federal loan rule
December 12, 2025
Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.